Core Insights - The brain-computer interface (BCI) industry is entering a "golden development period," characterized by significant advancements from laboratory innovations to clinical applications [1][2][3] Group 1: Technological Advancements - In 2025, significant milestones were achieved in BCI technology, including the first clinical trials of flexible micro-invasive BCI systems and the first intervention-assisted trials for restoring limb function [2][3] - Three main technological routes are developing in parallel: invasive, semi-invasive, and non-invasive techniques, with invasive methods being central to medical rehabilitation due to their high signal acquisition precision [3][4] - The semi-invasive BCI system developed by Borui Kang Technology requires only a small hole in the skull for implantation, allowing patients to control movements through thought [4] Group 2: Clinical Applications and Breakthroughs - Clinical breakthroughs include the successful restoration of walking in patients with severe spinal cord injuries through innovative BCI technologies [3][4] - A variety of new BCI applications are emerging, such as a visual reconstruction system for visually impaired patients and a wireless, fully implanted BCI product that has completed its first clinical trial [10][11] Group 3: Industry Growth and Policy Support - The establishment of pricing regulations for BCI services by the National Medical Insurance Administration marks a significant step in integrating this technology into public healthcare [6][8] - Various regions, including Shanghai and the Guangdong-Hong Kong-Macau Greater Bay Area, are forming BCI innovation clusters to enhance industry capabilities and foster collaboration among enterprises, hospitals, and research institutions [7][8] Group 4: Future Prospects - Experts predict that 2026 will be a pivotal year for the BCI industry, with advancements in multi-disciplinary integration, clinical scalability, and diverse application scenarios [9][10] - The anticipated mass production of certain BCI devices will pave the way for a diversified application ecosystem, enhancing the potential for widespread commercial use [10][11]

来源：科技日报 手术后17天，瘫痪8年的患者能通过意念玩"贪吃蛇""马里奥赛车"游戏；另一位高位截瘫4年的患者，经 过两个月训练后，不仅恢复了自主抓握，还能重新签下自己的名字……在不久前举办的2025脑机接口大 会主论坛上，复旦大学附属华山医院院长毛颖分享的案例，让现场观众真切感受到脑机接口技术的力 量。 从实验室到手术台，从技术原型到临床产品，我国脑机接口产业正迎来前所未有的发展机遇，并加速迈 入"政策—标准—技术—产业—临床"协同发展的"黄金发展期"。 三大技术路线并行发展 刚刚过去的2025年，被业内称为中国脑机接口发展"元年"。 2025年5月，上海阶梯医疗科技有限公司发布了超柔性微创植入式脑机接口系统的前瞻性临床试验进 展；6月，南开大学教授段峰团队牵头开展的全球首例介入式脑机接口辅助人体患肢运动功能修复试验 完成；11月，武汉衷华脑机融合科技发展有限公司与华中科技大学同济医学院附属协和医院合作，完成 全国产自主研发脑机接口芯片的首例临床植入手术……脑机接口技术创新愈加贴合患者需求，一系列临 床突破相继落地。 临床成果加速涌现背后，是侵入式、半侵入式、非侵入式三大技术路线的并行发展。 侵入式技术因信 ...